/PRZWT/HANGZHOU, Jan. 14, 2025 - Yiling Pharmaceutical won the "2024 Silver Persimmon Award · ESG Outstanding Performance" award at the "Silver Persimmon Award" ceremony hosted by Flush and Silver Persimmon Finance in Hangzhou on Jan. 10.
It is reported that the "Silver Persimmon Award" adheres to the concept of value investment, with the purpose of guiding the healthy and compliant development of the industry and creating greater value for high-quality brands. It targets key industries such as listed companies and Financial Institution Groups, combines the company's operating conditions, market ratings, and public opinion guidance, and comprehensively analyzes to select high-quality companies in the industry. The establishment of the "Silver Persimmon Award" aims to encourage major enterprises to adhere to the concept of high-quality development, pay attention to scientific and technological innovation, improve corporate governance, assume corporate social responsibility, and contribute to the sustainable development of our country's economy.
In recent years, ESG construction has gradually attracted widespread attention, which not only reflects the social responsibility of enterprises, but also becomes an important criterion for evaluating the future potential of enterprises. Since its establishment more than 30 years ago, Yiling Pharmaceutical has always adhered to technological innovation as the first driving force, increased investment in scientific and technological innovation, and achieved a series of fruitful scientific research results.
Yiling Pharmaceutical has performed well in ESG, actively practiced social responsibility, always adhering to the corporate tenet of "inheriting innovation and benefiting mankind", actively practiced the concept of green and low-carbon in the production and operation process, focused on rural revitalization, community construction and national health and other charitable public welfare undertakings, and contributed a steady stream of Yiling strength on the road of sustainable development.
